Hochschulschrift
Regulation of human androgen receptor by corepressors and signal transduction in prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Gießen, Univ., Diss., 2006
- Keyword
-
Fortpflanzung
Geschlechtsorgan
Urogenitalsystem
Geschlechtliche Fortpflanzung
Genexpression
Genregulation
Repression
Biochemische Analyse
Tierphysiologie
Mammologie
Plazentatiere
Säugetiere
- Creator
- URN
-
urn:nbn:de:hebis:26-opus-37199
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:44 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Androgen receptor expression in the clinically localized prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
TRIM25 controls the Androgen Receptor and PSA/KLK3 levels in Prostate Cancer
Small molecule BAG1L inhibitors for the treatment of androgen receptor-dependent prostate cancer
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Approaching personalized medicine: preclinical evaluation of enzalutamide-resistant castration-resistant prostate cancer and mutated forms of the androgen receptor targeted by a new androgen receptor inhibitor
Analysis of senescence-associated secretory phenotype induced by different androgen receptor ligands in human prostate cancer cells
The nuclear chaperones NPM1 and Bag-1L in the regulation of androgen receptor action in prostate cancer cells
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells
Transcriptome analysis of androgen-induced cellular senescence in prostate cancer cell lines
Androgen receptor expression in the clinically localized prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
TRIM25 controls the Androgen Receptor and PSA/KLK3 levels in Prostate Cancer
Small molecule BAG1L inhibitors for the treatment of androgen receptor-dependent prostate cancer
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Approaching personalized medicine: preclinical evaluation of enzalutamide-resistant castration-resistant prostate cancer and mutated forms of the androgen receptor targeted by a new androgen receptor inhibitor
Analysis of senescence-associated secretory phenotype induced by different androgen receptor ligands in human prostate cancer cells
The nuclear chaperones NPM1 and Bag-1L in the regulation of androgen receptor action in prostate cancer cells
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells
Transcriptome analysis of androgen-induced cellular senescence in prostate cancer cell lines
Androgen receptor expression in the clinically localized prostate cancer
Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer
TRIM25 controls the Androgen Receptor and PSA/KLK3 levels in Prostate Cancer
Small molecule BAG1L inhibitors for the treatment of androgen receptor-dependent prostate cancer
Analysis of regulation of angiogenesis by androgen receptor ligands in castration-resistant prostate cancer
Prognostic significance of androgen receptor splice variant 7 and glucocorticoid receptor expression in high-risk prostate cancer
Approaching personalized medicine: preclinical evaluation of enzalutamide-resistant castration-resistant prostate cancer and mutated forms of the androgen receptor targeted by a new androgen receptor inhibitor
Analysis of senescence-associated secretory phenotype induced by different androgen receptor ligands in human prostate cancer cells
The nuclear chaperones NPM1 and Bag-1L in the regulation of androgen receptor action in prostate cancer cells
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells